-transparent.png){kind=logo}
Proliferating cultured P388 cells exhibited a greater degree of sensitivity to adriamycin than did proliferating cultured L1210 cells, although both leukemia cell populations had approximately the same doubling time. The rate of reduction in viability when cultured L1210 cell populations were exposed to adriamycin (0.0625-2.0 microgram/ml, concentrations that are comparable to tissue drug levels during therapy) was concentration-dependent. Therefore, the results indicated a possible therapeutic advantage to be gained by an increase in drug concentrations (within the limits of acceptable host toxicity) at the target cell site.
Related Publications
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
February 1968,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
January 1983,
Oncology,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
May 1984,
Cancer research,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
December 1978,
Journal of the National Cancer Institute,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
April 1989,
Tumori,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
March 1995,
Biological & pharmaceutical bulletin,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
January 1990,
Selective cancer therapeutics,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
January 1996,
Nutrition and cancer,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
November 1981,
Chemico-biological interactions,
L J Wilkott, and
E A Dulmadge, and
H H Lloyd
August 1984,
Tumori,
